Inhalation Sciences Sweden AB Share Price Börse Stuttgart
Stocks
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Börse Stuttgart
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 28/08 | Inhalation Sciences receives SEK 0.5m from warrants | FW |
| 24/08 | Inhalation Sciences Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 71.68L 7L 6L 6L 6L 10.32L 7.07Cr 10.35L 27.71L 3.62Cr 28.07L 27.45L 12Cr | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 43.37L 5L 4L 4L 3L 6L 4.28Cr 6L 16.76L 2.19Cr 16.98L 16.61L 6.98Cr | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
99.4% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7L | |
| -0.75% | -0.54% | +24.60% | +15.45% | 23TCr | |
| -1.60% | -2.76% | +3.72% | -18.54% | 15TCr | |
| -0.85% | -2.70% | -21.45% | +23.38% | 13TCr | |
| +1.81% | -1.04% | -55.42% | -11.30% | 6.93TCr | |
| +0.13% | -0.94% | +11.07% | +18.15% | 5.18TCr | |
| +0.92% | -0.84% | -18.03% | -12.76% | 5TCr | |
| +0.59% | -1.76% | +17.17% | +29.76% | 4.25TCr | |
| -1.01% | -1.27% | +33.64% | +51.45% | 4.02TCr | |
| -1.55% | +2.15% | +120.58% | +37.37% | 3.3TCr | |
| Average | -0.41% | -0.93% | +12.88% | +14.77% | 8.77TCr | |
| Weighted average by Cap. | -0.58% | -1.41% | +6.64% | +10.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.1Cr 11.52L 10L 9L 9L 15.91L 11Cr 15.96L 42.7L 5.58Cr 43.26L 42.31L 18Cr | 30.41L 3L 3L 3L 2L 4L 3Cr 4L 11.75L 1.54Cr 11.91L 11.65L 4.89Cr |
| Net income | -51.47L -5L -5L -4L -4L -7L -5.08Cr -7L -19.9L -2.6Cr -20.15L -19.71L -8.28Cr | -1.02Cr -10.59L -9L -9L -8L -14.63L -10Cr -14.68L -39.27L -5.13Cr -39.78L -38.91L -16Cr |
| Net Debt | -40.03L -4L -4L -3L -3L -6L -3.95Cr -6L -15.47L -2.02Cr -15.67L -15.33L -6.44Cr | -28.31L -3L -3L -2L -2L -4L -2.79Cr -4L -10.94L -1.43Cr -11.09L -10.84L -4.55Cr |
Employees
5
Net sales - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
